Current Opinion in Molecular Therapeutics is published bimonthly and covers the broad field of molecular medicine, including viral and non-viral gene therapy, oligonucleotides, peptide therapeutics, antibody approaches, molecular vaccines, and the technologies underlying genomics and proteomics.

Access to the full text or PDF of articles from Current Opinion in Molecular Therapeutics requires a subscription to the journal. Individual PDFs may be purchased by contacting ts.ids@thomson.com.